<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(28)</volume><submitter>Tao X</submitter><pubmed_abstract>In this research, ovalbumin (OVA) and sodium alginate (SA) were used as the materials to prepare an OVA-SA composite carrier, which protected and encapsulated the hydrophobic kaempferol (KAE) and the hydrophilic tannic acid (TA) (OVA-SA, OVA-TA-SA, OVA-KAE-SA, and OVA-TA-KAE-SA). Results showed that the observation of small diffraction peaks in carriers proved the successful encapsulation of KAE/TA. The protein conformation of the composite nanoparticles changed. OVA-TA-SA composite nanoparticles had the highest α-helix content and the fewest random coils, so the protein structure of it had the strongest stability. OVA-TA-KAE-SA composite nanoparticles had the strongest system stability and thermal stability, which might be due to the synergistic effect of the two polyphenols, suggesting the encapsulation of KAE/TA increased the system stability and the thermal stability of OVA-SA composite nanoparticles. Additionally, the composite nanoparticles were endowed with antioxidant ability and antibacterial ability (against &lt;i>Staphylococcus aureus&lt;/i> and &lt;i>Escherichia coli&lt;/i>) in the order OVA-TA-SA > OVA-TA-KAE-SA > OVA-KAE-SA based on the difference in antibacterial diameter (&lt;i>D&lt;/i>, mm) and square (&lt;i>S&lt;/i>, mm&lt;sup>2&lt;/sup>), indicating that polyphenols enhanced the antibacterial and antioxidant ability of OVA-SA composite nanoparticles, and the enhancement effect of TA was stronger than that of KAE. These results provide a theoretical basis for the application of OVA-SA composite nanoparticles in the delivery of bioactive compounds.</pubmed_abstract><journal>RSC advances</journal><pagination>18115-18126</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9245490</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Understanding of physicochemical properties and antioxidant activity of ovalbumin-sodium alginate composite nanoparticle-encapsulated kaempferol/tannin acid.</pubmed_title><pmcid>PMC9245490</pmcid><pubmed_authors>Tao X</pubmed_authors><pubmed_authors>Cai L</pubmed_authors><pubmed_authors>Shi H</pubmed_authors><pubmed_authors>Cao A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Understanding of physicochemical properties and antioxidant activity of ovalbumin-sodium alginate composite nanoparticle-encapsulated kaempferol/tannin acid.</name><description>In this research, ovalbumin (OVA) and sodium alginate (SA) were used as the materials to prepare an OVA-SA composite carrier, which protected and encapsulated the hydrophobic kaempferol (KAE) and the hydrophilic tannic acid (TA) (OVA-SA, OVA-TA-SA, OVA-KAE-SA, and OVA-TA-KAE-SA). Results showed that the observation of small diffraction peaks in carriers proved the successful encapsulation of KAE/TA. The protein conformation of the composite nanoparticles changed. OVA-TA-SA composite nanoparticles had the highest α-helix content and the fewest random coils, so the protein structure of it had the strongest stability. OVA-TA-KAE-SA composite nanoparticles had the strongest system stability and thermal stability, which might be due to the synergistic effect of the two polyphenols, suggesting the encapsulation of KAE/TA increased the system stability and the thermal stability of OVA-SA composite nanoparticles. Additionally, the composite nanoparticles were endowed with antioxidant ability and antibacterial ability (against &lt;i>Staphylococcus aureus&lt;/i> and &lt;i>Escherichia coli&lt;/i>) in the order OVA-TA-SA > OVA-TA-KAE-SA > OVA-KAE-SA based on the difference in antibacterial diameter (&lt;i>D&lt;/i>, mm) and square (&lt;i>S&lt;/i>, mm&lt;sup>2&lt;/sup>), indicating that polyphenols enhanced the antibacterial and antioxidant ability of OVA-SA composite nanoparticles, and the enhancement effect of TA was stronger than that of KAE. These results provide a theoretical basis for the application of OVA-SA composite nanoparticles in the delivery of bioactive compounds.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2024-10-17T13:50:03.827Z</modification><creation>2024-10-17T13:50:03.827Z</creation></dates><accession>S-EPMC9245490</accession><cross_references><pubmed>35874031</pubmed><doi>10.1039/d2ra02708a</doi></cross_references></HashMap>